Skip to content
zameds

Vildagliptin, metformin (Galvus Met, Jalramet)

Vildagliptin, metformin

Novartis South Africa (Pty) Ltd

S3

Registration

Applicant
Novartis South Africa (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Galvus met 50 mg/850 MG

EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg

50 mg/850 mg43105543/21.2/1055RegisteredS3None
Galvus met 50 mg/1000 MG

EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg

50 mg/1000 mg43105643/21.2/1056RegisteredS3None
Jalramet 50/850 MG

EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg ,METFORMIN HYDROCHLORIDE 850,0 mg

50/850 mg48072948/21.2/0729RegisteredS3None
Jalramet 50/1 000 MG

EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg

000 mg 50/148073048/21.2/0730RegisteredS3None

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, matched to the Consolidated Schedules by ingredient, confidence medium.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Vildagliptin, metformin hydrochloride

  • S3: Metformin

    Consolidated Schedules 06 July 2026, line 3938

  • S3: Vildagliptin

    Consolidated Schedules 06 July 2026, line 4386

Pharmacological class: Oral hypoglycaemics. (class 21.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles